| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Median Arcuate Ligament Syndrome | 7 | 2023 | 23 | 2.540 |
Why?
|
| Peripheral Arterial Disease | 6 | 2024 | 102 | 1.680 |
Why?
|
| Myocytes, Smooth Muscle | 5 | 2015 | 141 | 1.360 |
Why?
|
| Abdominal Pain | 6 | 2023 | 145 | 1.300 |
Why?
|
| Celiac Artery | 4 | 2023 | 25 | 1.240 |
Why?
|
| Muscle, Smooth, Vascular | 7 | 2015 | 243 | 1.190 |
Why?
|
| Vascular Surgical Procedures | 8 | 2018 | 152 | 1.160 |
Why?
|
| Tunica Intima | 5 | 2015 | 61 | 1.080 |
Why?
|
| Blood Vessel Prosthesis Implantation | 14 | 2018 | 239 | 0.990 |
Why?
|
| Lower Extremity | 4 | 2024 | 98 | 0.930 |
Why?
|
| Constriction, Pathologic | 3 | 2016 | 220 | 0.930 |
Why?
|
| Carotid Stenosis | 7 | 2012 | 115 | 0.900 |
Why?
|
| Arterial Occlusive Diseases | 4 | 2016 | 111 | 0.850 |
Why?
|
| Stents | 7 | 2018 | 425 | 0.840 |
Why?
|
| Herpesvirus 1, Human | 4 | 2015 | 245 | 0.810 |
Why?
|
| Endovascular Procedures | 4 | 2024 | 334 | 0.790 |
Why?
|
| Cell Proliferation | 4 | 2015 | 1755 | 0.730 |
Why?
|
| Carotid Artery, Internal | 4 | 2012 | 70 | 0.680 |
Why?
|
| Aortic Aneurysm, Abdominal | 4 | 2018 | 121 | 0.660 |
Why?
|
| Endarterectomy, Carotid | 4 | 2012 | 76 | 0.640 |
Why?
|
| Chronic Pain | 3 | 2018 | 186 | 0.630 |
Why?
|
| Decompression, Surgical | 3 | 2018 | 168 | 0.620 |
Why?
|
| Angioplasty, Balloon | 2 | 2009 | 100 | 0.550 |
Why?
|
| Hyperplasia | 6 | 2015 | 149 | 0.530 |
Why?
|
| Apoptosis | 3 | 2008 | 1760 | 0.530 |
Why?
|
| Mental Disorders | 2 | 2018 | 463 | 0.520 |
Why?
|
| Ultrasonography, Doppler, Duplex | 5 | 2019 | 42 | 0.520 |
Why?
|
| Quality of Life | 4 | 2021 | 1816 | 0.480 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2018 | 286 | 0.480 |
Why?
|
| Laparoscopy | 4 | 2018 | 784 | 0.470 |
Why?
|
| Peripheral Vascular Diseases | 3 | 2013 | 62 | 0.470 |
Why?
|
| Graft Occlusion, Vascular | 4 | 2018 | 100 | 0.460 |
Why?
|
| Ligaments | 1 | 2013 | 34 | 0.410 |
Why?
|
| Rabbits | 9 | 2015 | 639 | 0.410 |
Why?
|
| Simplexvirus | 2 | 2012 | 150 | 0.390 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2013 | 67 | 0.390 |
Why?
|
| Aortic Diseases | 3 | 2009 | 104 | 0.380 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2012 | 38 | 0.370 |
Why?
|
| Coronary Disease | 1 | 2013 | 263 | 0.360 |
Why?
|
| Iliac Artery | 2 | 2009 | 42 | 0.350 |
Why?
|
| Risk Factors | 10 | 2024 | 5960 | 0.350 |
Why?
|
| Mass Screening | 1 | 2016 | 710 | 0.350 |
Why?
|
| Humans | 53 | 2024 | 96093 | 0.350 |
Why?
|
| Male | 41 | 2024 | 45871 | 0.350 |
Why?
|
| Coronary Vessels | 1 | 2013 | 201 | 0.350 |
Why?
|
| Leg | 5 | 2003 | 143 | 0.340 |
Why?
|
| Carotid Arteries | 1 | 2012 | 136 | 0.340 |
Why?
|
| Treatment Outcome | 18 | 2018 | 9173 | 0.320 |
Why?
|
| Aneurysm, False | 2 | 2007 | 55 | 0.320 |
Why?
|
| Angioplasty | 2 | 2007 | 71 | 0.310 |
Why?
|
| Carotid Artery Injuries | 1 | 2008 | 22 | 0.290 |
Why?
|
| Veins | 5 | 2009 | 94 | 0.290 |
Why?
|
| Endoleak | 3 | 2019 | 42 | 0.280 |
Why?
|
| Blood Vessel Prosthesis | 5 | 2018 | 248 | 0.280 |
Why?
|
| Calcinosis | 1 | 2009 | 232 | 0.280 |
Why?
|
| Aneurysm, Infected | 1 | 2007 | 15 | 0.270 |
Why?
|
| Brachial Artery | 1 | 2007 | 36 | 0.270 |
Why?
|
| Exercise Therapy | 2 | 2018 | 94 | 0.260 |
Why?
|
| Nicotinic Agonists | 1 | 2008 | 74 | 0.260 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2007 | 66 | 0.260 |
Why?
|
| Retrospective Studies | 16 | 2024 | 10286 | 0.250 |
Why?
|
| Female | 30 | 2024 | 50030 | 0.250 |
Why?
|
| Nicotine | 1 | 2008 | 210 | 0.240 |
Why?
|
| Aged | 22 | 2024 | 20962 | 0.240 |
Why?
|
| Middle Aged | 23 | 2024 | 28361 | 0.240 |
Why?
|
| Hemodynamics | 5 | 2008 | 781 | 0.230 |
Why?
|
| Adolescent | 9 | 2020 | 9896 | 0.230 |
Why?
|
| Vascular Patency | 8 | 2009 | 127 | 0.230 |
Why?
|
| Time Factors | 11 | 2018 | 5585 | 0.220 |
Why?
|
| Inflammation Mediators | 2 | 2015 | 163 | 0.210 |
Why?
|
| Thoracoscopy | 1 | 2003 | 21 | 0.210 |
Why?
|
| Thymectomy | 1 | 2003 | 32 | 0.210 |
Why?
|
| Genetic Vectors | 2 | 2003 | 446 | 0.210 |
Why?
|
| Myocardial Ischemia | 2 | 2015 | 167 | 0.200 |
Why?
|
| Aged, 80 and over | 9 | 2024 | 7230 | 0.200 |
Why?
|
| Treatment Failure | 1 | 2024 | 297 | 0.200 |
Why?
|
| Myasthenia Gravis | 1 | 2003 | 83 | 0.200 |
Why?
|
| Ischemia | 5 | 2009 | 257 | 0.200 |
Why?
|
| Saphenous Vein | 5 | 2002 | 61 | 0.190 |
Why?
|
| Risk Assessment | 3 | 2024 | 2480 | 0.190 |
Why?
|
| Blood Flow Velocity | 6 | 2019 | 202 | 0.190 |
Why?
|
| Logistic Models | 2 | 2024 | 1268 | 0.180 |
Why?
|
| Comorbidity | 4 | 2018 | 1011 | 0.180 |
Why?
|
| Reoperation | 4 | 2013 | 707 | 0.180 |
Why?
|
| Unnecessary Procedures | 1 | 2002 | 55 | 0.180 |
Why?
|
| Limb Salvage | 3 | 2009 | 38 | 0.170 |
Why?
|
| Preoperative Care | 2 | 2013 | 418 | 0.170 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2013 | 2781 | 0.170 |
Why?
|
| Walking | 2 | 2018 | 106 | 0.160 |
Why?
|
| Vascular System Injuries | 1 | 2020 | 37 | 0.160 |
Why?
|
| Foreign Bodies | 1 | 2020 | 66 | 0.160 |
Why?
|
| Child | 5 | 2019 | 7626 | 0.160 |
Why?
|
| Aorta, Thoracic | 1 | 2020 | 171 | 0.150 |
Why?
|
| Vena Cava, Inferior | 1 | 2020 | 143 | 0.150 |
Why?
|
| Environmental Health | 1 | 2019 | 10 | 0.150 |
Why?
|
| Child Mortality | 1 | 2019 | 9 | 0.150 |
Why?
|
| Genetic Therapy | 1 | 2001 | 382 | 0.150 |
Why?
|
| Child Health | 1 | 2019 | 13 | 0.150 |
Why?
|
| Public Health | 1 | 2020 | 155 | 0.150 |
Why?
|
| Follow-Up Studies | 6 | 2018 | 3927 | 0.140 |
Why?
|
| Wounds, Gunshot | 1 | 2020 | 121 | 0.140 |
Why?
|
| Cost of Illness | 2 | 2018 | 161 | 0.140 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2018 | 41 | 0.140 |
Why?
|
| Home Nursing | 1 | 2018 | 19 | 0.140 |
Why?
|
| Proliferating Cell Nuclear Antigen | 2 | 2008 | 68 | 0.140 |
Why?
|
| Caspase 3 | 2 | 2008 | 164 | 0.140 |
Why?
|
| Wearable Electronic Devices | 1 | 2018 | 36 | 0.140 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2017 | 114 | 0.130 |
Why?
|
| Femoral Artery | 3 | 2009 | 91 | 0.130 |
Why?
|
| Mental Health | 1 | 2018 | 202 | 0.130 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2018 | 884 | 0.130 |
Why?
|
| Ecosystem | 1 | 2020 | 394 | 0.130 |
Why?
|
| Pain Measurement | 1 | 2018 | 378 | 0.130 |
Why?
|
| Computed Tomography Angiography | 1 | 2018 | 166 | 0.130 |
Why?
|
| Regional Blood Flow | 4 | 2018 | 198 | 0.120 |
Why?
|
| Thrombosis | 2 | 2014 | 326 | 0.120 |
Why?
|
| Chi-Square Distribution | 2 | 2018 | 363 | 0.120 |
Why?
|
| Kidney Transplantation | 1 | 2002 | 882 | 0.120 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2015 | 32 | 0.120 |
Why?
|
| Aneurysm, Ruptured | 2 | 2006 | 62 | 0.120 |
Why?
|
| Stress, Mechanical | 3 | 2008 | 261 | 0.120 |
Why?
|
| Animals | 10 | 2015 | 28915 | 0.110 |
Why?
|
| Prospective Studies | 3 | 2018 | 4671 | 0.110 |
Why?
|
| Carotid Artery, Common | 3 | 2008 | 28 | 0.110 |
Why?
|
| Adult | 10 | 2018 | 28716 | 0.100 |
Why?
|
| Enteric Nervous System | 1 | 2013 | 7 | 0.100 |
Why?
|
| Proportional Hazards Models | 3 | 2012 | 901 | 0.100 |
Why?
|
| Jugular Veins | 3 | 2005 | 73 | 0.100 |
Why?
|
| Sex Distribution | 1 | 2013 | 175 | 0.100 |
Why?
|
| Early Diagnosis | 1 | 2013 | 137 | 0.100 |
Why?
|
| Diaphragm | 1 | 2013 | 75 | 0.100 |
Why?
|
| Ultrasonography, Interventional | 1 | 2013 | 125 | 0.100 |
Why?
|
| Mutation | 4 | 2012 | 4374 | 0.090 |
Why?
|
| Leptospirosis | 1 | 2012 | 3 | 0.090 |
Why?
|
| Radiography | 4 | 2007 | 826 | 0.090 |
Why?
|
| Disease Progression | 2 | 2015 | 1564 | 0.090 |
Why?
|
| Hemostatics | 1 | 2012 | 61 | 0.090 |
Why?
|
| Vascular Resistance | 2 | 2002 | 104 | 0.090 |
Why?
|
| Pediatrics | 1 | 2016 | 399 | 0.090 |
Why?
|
| Embolization, Therapeutic | 2 | 2012 | 279 | 0.090 |
Why?
|
| Aortography | 2 | 2009 | 67 | 0.090 |
Why?
|
| Cell Movement | 1 | 2015 | 816 | 0.090 |
Why?
|
| Lumbosacral Plexus | 1 | 2011 | 11 | 0.090 |
Why?
|
| Spinal Nerve Roots | 1 | 2011 | 21 | 0.090 |
Why?
|
| ras Proteins | 1 | 2012 | 134 | 0.090 |
Why?
|
| Radiography, Interventional | 1 | 2012 | 154 | 0.090 |
Why?
|
| Pelvic Neoplasms | 1 | 2011 | 45 | 0.080 |
Why?
|
| Neurilemmoma | 1 | 2011 | 41 | 0.080 |
Why?
|
| Carotid Artery, External | 2 | 2008 | 9 | 0.080 |
Why?
|
| Young Adult | 3 | 2018 | 7025 | 0.080 |
Why?
|
| Chronic Disease | 1 | 2013 | 983 | 0.080 |
Why?
|
| Research Design | 1 | 2014 | 631 | 0.080 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2011 | 81 | 0.080 |
Why?
|
| Cells, Cultured | 1 | 2015 | 2940 | 0.080 |
Why?
|
| Patient Satisfaction | 1 | 2013 | 514 | 0.080 |
Why?
|
| Environment | 1 | 2012 | 231 | 0.080 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 1010 | 0.080 |
Why?
|
| Atherectomy | 1 | 2009 | 4 | 0.080 |
Why?
|
| Rupture | 1 | 2009 | 62 | 0.080 |
Why?
|
| Shear Strength | 1 | 2008 | 17 | 0.070 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2008 | 124 | 0.070 |
Why?
|
| Recurrence | 2 | 2002 | 1218 | 0.070 |
Why?
|
| Popliteal Artery | 2 | 2006 | 30 | 0.070 |
Why?
|
| Predictive Value of Tests | 5 | 2018 | 1807 | 0.070 |
Why?
|
| Polytetrafluoroethylene | 3 | 2002 | 74 | 0.070 |
Why?
|
| Ligation | 1 | 2007 | 53 | 0.070 |
Why?
|
| Collateral Circulation | 1 | 2007 | 41 | 0.070 |
Why?
|
| Cell Line | 1 | 2012 | 2534 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2008 | 797 | 0.060 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2006 | 277 | 0.060 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 124 | 0.060 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2008 | 98 | 0.060 |
Why?
|
| Survival Analysis | 4 | 2003 | 1546 | 0.060 |
Why?
|
| Brachiocephalic Trunk | 1 | 2006 | 14 | 0.060 |
Why?
|
| Arteries | 1 | 2007 | 181 | 0.060 |
Why?
|
| Homeostasis | 1 | 2008 | 467 | 0.060 |
Why?
|
| Robotics | 1 | 2008 | 273 | 0.060 |
Why?
|
| Pulsatile Flow | 2 | 2001 | 52 | 0.050 |
Why?
|
| Smoking | 1 | 2008 | 653 | 0.050 |
Why?
|
| Models, Animal | 2 | 2001 | 286 | 0.050 |
Why?
|
| Stroke | 1 | 2012 | 1087 | 0.050 |
Why?
|
| Thrombophilia | 1 | 2003 | 23 | 0.050 |
Why?
|
| Blood Circulation | 1 | 2002 | 31 | 0.050 |
Why?
|
| Viscera | 1 | 2002 | 19 | 0.050 |
Why?
|
| Iliac Aneurysm | 1 | 2002 | 8 | 0.050 |
Why?
|
| Radial Artery | 1 | 2002 | 37 | 0.050 |
Why?
|
| Embolism | 1 | 2002 | 34 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2003 | 123 | 0.050 |
Why?
|
| Prosthesis Design | 2 | 2018 | 310 | 0.050 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2002 | 12 | 0.050 |
Why?
|
| Models, Cardiovascular | 1 | 2002 | 110 | 0.050 |
Why?
|
| Carotid Artery Diseases | 1 | 2002 | 103 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 224 | 0.050 |
Why?
|
| Organ Culture Techniques | 1 | 2001 | 128 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2002 | 692 | 0.040 |
Why?
|
| Hemorheology | 1 | 2001 | 8 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2012 | 3581 | 0.040 |
Why?
|
| Arteriosclerosis | 1 | 2001 | 112 | 0.040 |
Why?
|
| Postoperative Care | 1 | 2002 | 239 | 0.040 |
Why?
|
| Gene Transfer Techniques | 1 | 2001 | 156 | 0.040 |
Why?
|
| Thoracotomy | 1 | 2020 | 68 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2015 | 1958 | 0.040 |
Why?
|
| Blood Pressure | 2 | 2002 | 929 | 0.040 |
Why?
|
| Circadian Rhythm | 1 | 2002 | 300 | 0.040 |
Why?
|
| Kidney Failure, Chronic | 2 | 2001 | 432 | 0.040 |
Why?
|
| Heart Rate | 1 | 2002 | 519 | 0.040 |
Why?
|
| Salvage Therapy | 1 | 2001 | 238 | 0.040 |
Why?
|
| Transfection | 1 | 2001 | 908 | 0.040 |
Why?
|
| Myocardial Contraction | 1 | 2001 | 253 | 0.040 |
Why?
|
| Conservation of Natural Resources | 1 | 2020 | 98 | 0.040 |
Why?
|
| Bhutan | 1 | 2019 | 3 | 0.040 |
Why?
|
| Hospital Costs | 1 | 2000 | 117 | 0.040 |
Why?
|
| Sri Lanka | 1 | 2019 | 3 | 0.040 |
Why?
|
| Vietnam | 1 | 2019 | 15 | 0.040 |
Why?
|
| Nepal | 1 | 2019 | 17 | 0.040 |
Why?
|
| Asia, Southeastern | 1 | 2019 | 18 | 0.040 |
Why?
|
| Sanitation | 1 | 2019 | 6 | 0.040 |
Why?
|
| Sex Factors | 2 | 2018 | 1133 | 0.040 |
Why?
|
| Thailand | 1 | 2019 | 66 | 0.040 |
Why?
|
| Aortic Aneurysm | 1 | 2019 | 82 | 0.040 |
Why?
|
| Child Nutrition Disorders | 1 | 2019 | 13 | 0.040 |
Why?
|
| Chicago | 3 | 2015 | 1503 | 0.040 |
Why?
|
| Pesticides | 1 | 2019 | 30 | 0.040 |
Why?
|
| Growth Disorders | 1 | 2019 | 66 | 0.040 |
Why?
|
| India | 1 | 2019 | 138 | 0.040 |
Why?
|
| Pediatric Obesity | 1 | 2019 | 32 | 0.040 |
Why?
|
| Drinking Water | 1 | 2019 | 70 | 0.040 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2019 | 157 | 0.040 |
Why?
|
| Retreatment | 1 | 2018 | 106 | 0.030 |
Why?
|
| Telephone | 1 | 2018 | 36 | 0.030 |
Why?
|
| Biomarkers | 2 | 2015 | 1932 | 0.030 |
Why?
|
| Bangladesh | 1 | 2019 | 339 | 0.030 |
Why?
|
| Intermittent Claudication | 1 | 2017 | 22 | 0.030 |
Why?
|
| Walk Test | 1 | 2017 | 30 | 0.030 |
Why?
|
| Biodiversity | 1 | 2020 | 238 | 0.030 |
Why?
|
| Coronary Artery Disease | 1 | 2002 | 394 | 0.030 |
Why?
|
| Pressure | 3 | 2002 | 175 | 0.030 |
Why?
|
| Air Pollution | 1 | 2019 | 107 | 0.030 |
Why?
|
| Adaptation, Psychological | 1 | 2018 | 174 | 0.030 |
Why?
|
| Analgesics | 1 | 2018 | 132 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2018 | 2860 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2018 | 239 | 0.030 |
Why?
|
| Self Report | 1 | 2018 | 328 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2018 | 348 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2018 | 504 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 1981 | 0.030 |
Why?
|
| Environmental Exposure | 1 | 2019 | 357 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2012 | 2040 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 296 | 0.030 |
Why?
|
| Stem Cells | 1 | 2017 | 394 | 0.030 |
Why?
|
| Telemedicine | 1 | 2018 | 229 | 0.030 |
Why?
|
| Rupture, Spontaneous | 2 | 2006 | 43 | 0.030 |
Why?
|
| Hospitalization | 1 | 2000 | 943 | 0.030 |
Why?
|
| Postoperative Complications | 2 | 2002 | 2591 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 1773 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2015 | 740 | 0.020 |
Why?
|
| Registries | 1 | 2018 | 986 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2019 | 2614 | 0.020 |
Why?
|
| American Samoa | 1 | 2012 | 1 | 0.020 |
Why?
|
| Geographic Information Systems | 1 | 2012 | 28 | 0.020 |
Why?
|
| Infant | 1 | 2019 | 3363 | 0.020 |
Why?
|
| Seroepidemiologic Studies | 1 | 2012 | 57 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2019 | 3974 | 0.020 |
Why?
|
| Back Pain | 1 | 2011 | 76 | 0.020 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2011 | 76 | 0.020 |
Why?
|
| Constipation | 1 | 2011 | 69 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2012 | 713 | 0.020 |
Why?
|
| Prognosis | 1 | 2015 | 4029 | 0.020 |
Why?
|
| Length of Stay | 2 | 2002 | 833 | 0.020 |
Why?
|
| Angiography | 1 | 2007 | 209 | 0.020 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2008 | 118 | 0.020 |
Why?
|
| Critical Illness | 1 | 2009 | 346 | 0.020 |
Why?
|
| Vascular Fistula | 1 | 2006 | 12 | 0.020 |
Why?
|
| Respiratory Tract Fistula | 1 | 2006 | 9 | 0.020 |
Why?
|
| Tracheal Diseases | 1 | 2006 | 14 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 1874 | 0.020 |
Why?
|
| Emergency Treatment | 1 | 2006 | 48 | 0.010 |
Why?
|
| Tracheostomy | 1 | 2006 | 46 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 2883 | 0.010 |
Why?
|
| ROC Curve | 1 | 2008 | 797 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2003 | 3107 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 2003 | 2550 | 0.010 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2006 | 162 | 0.010 |
Why?
|
| Immediate-Early Proteins | 1 | 2005 | 164 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2005 | 185 | 0.010 |
Why?
|
| Umbilical Arteries | 1 | 2003 | 15 | 0.010 |
Why?
|
| Inguinal Canal | 1 | 2003 | 6 | 0.010 |
Why?
|
| Venous Thrombosis | 1 | 2006 | 257 | 0.010 |
Why?
|
| Sinoatrial Node | 1 | 2002 | 12 | 0.010 |
Why?
|
| Serologic Tests | 1 | 2003 | 43 | 0.010 |
Why?
|
| Macaca fascicularis | 1 | 2002 | 112 | 0.010 |
Why?
|
| Rheology | 1 | 2002 | 42 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 1034 | 0.010 |
Why?
|
| Culture Media | 1 | 2002 | 150 | 0.010 |
Why?
|
| Fourier Analysis | 1 | 2002 | 128 | 0.010 |
Why?
|
| Coronary Stenosis | 1 | 2002 | 40 | 0.010 |
Why?
|
| Polyethylene Terephthalates | 1 | 2002 | 19 | 0.010 |
Why?
|
| Time | 1 | 2002 | 79 | 0.010 |
Why?
|
| Femoral Vein | 1 | 2002 | 42 | 0.010 |
Why?
|
| Aorta, Abdominal | 1 | 2002 | 60 | 0.010 |
Why?
|
| Triglycerides | 1 | 2002 | 236 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2002 | 236 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2002 | 220 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2003 | 1010 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2002 | 246 | 0.010 |
Why?
|
| Perfusion | 1 | 2002 | 266 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2002 | 273 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2003 | 437 | 0.010 |
Why?
|
| Cell Survival | 1 | 2003 | 1030 | 0.010 |
Why?
|
| Life Tables | 1 | 2000 | 47 | 0.010 |
Why?
|
| Catheter Ablation | 1 | 2002 | 266 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2001 | 342 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2001 | 283 | 0.010 |
Why?
|
| Cell Division | 1 | 2001 | 705 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 2000 | 157 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2002 | 483 | 0.010 |
Why?
|
| Biomechanical Phenomena | 1 | 2001 | 506 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2001 | 910 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 3651 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2000 | 362 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2001 | 819 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 1985 | 0.010 |
Why?
|
| Graft Survival | 1 | 2001 | 942 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 1829 | 0.010 |
Why?
|
| Brain | 1 | 2006 | 2482 | 0.010 |
Why?
|
| Hypertension | 1 | 2001 | 777 | 0.010 |
Why?
|